In-vitro antibacterial activities of cefpiramide and other broad- spectrum antibiotics against 440 clinical isolates in China

Journal of Infection and Chemotherapy

Volumn 6, Issue 2, 2000, Pages 81-85

  Wang, Hui ^a   Yu, Yingchun ^a   Xie, Xiuli ^a   Wang, Cangzhcn ^a   Zhang, Yuexian ^a   Yuan, Ying ^a   Zhang, Xiaojiang ^a   Liu, Juan ^a   Wang, Peng ^a   Chen, Minjun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Cefpiramide; Cephalosporin; Clinical strains; MIC

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFPIRAMIDE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; OXACILLIN; PENICILLIN G; SULPERAZON; SULTAMICILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CHINA; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

EID: 12944255783     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012156     Document Type: Article

References (8)

1. Fass RJ, Helsel VL. In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli. Diagn Microbiol Infect Dis 1986;4:77-81.
2. Kato M, Inoue M, Mitsuhashi. Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1982;22:721-7.
3. Metzler CM, Dehaan RM. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis 1974;130:588-94.
4. National Committee for Clinical Laboratory Standards. Approved standard M7-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement. M100-S9, vol 19, no. 1. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.
6. Allan JD, Elipoulos GM, Ferraro MJ, Morellering RC, JR. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination. Antimicrob Agents Chemother 1985; 27:782-90.
7. Pfaller MA, Niles AC, Murray PR. In vitro antibacterial activity of cefpiramide. Antimicrob Agents Chemother 1984;25:368-72.
8. Pfaller MA, Bale M, Preston T, Howard W, Koontz F. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 1986;5:17-23.